InvestorsHub Logo
Followers 58
Posts 2505
Boards Moderated 0
Alias Born 09/21/2009

Re: ash111 post# 3842

Wednesday, 09/21/2016 6:16:47 PM

Wednesday, September 21, 2016 6:16:47 PM

Post# of 8449
Agree Ash. Talking the whole world here. Also, When looking at these numbers you have to put yourself into the buyout co. shoes (Teva, Pfizer, etc..) A large bio would already have a massive sales network established with Celebrex or generic version. The Right partner of kit-302 makes all the difference. The right partner could "Dominate the Market" with this so its more valuable to them.